Vancity Investment Management Ltd purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 32,539 shares of the financial services provider's stock, valued at approximately $8,632,000. CME Group comprises about 1.2% of Vancity Investment Management Ltd's investment portfolio, making the stock its 28th biggest holding.
Several other hedge funds and other institutional investors have also recently made changes to their positions in CME. GQG Partners LLC increased its position in shares of CME Group by 7,676.3% during the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider's stock valued at $584,975,000 after purchasing an additional 2,176,685 shares during the last quarter. Wellington Management Group LLP increased its position in shares of CME Group by 370.5% during the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider's stock valued at $704,068,000 after purchasing an additional 2,089,935 shares during the last quarter. GAMMA Investing LLC increased its position in shares of CME Group by 32,941.0% during the 1st quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after purchasing an additional 1,853,261 shares during the last quarter. Nuveen LLC purchased a new stake in shares of CME Group during the 1st quarter valued at about $218,842,000. Finally, Alliancebernstein L.P. increased its position in shares of CME Group by 185.5% during the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider's stock valued at $330,182,000 after purchasing an additional 808,740 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently commented on the stock. UBS Group reduced their price target on shares of CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Citigroup increased their target price on shares of CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a report on Thursday, July 3rd. Oppenheimer increased their target price on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a report on Thursday, July 24th. Barclays set a $298.00 target price on shares of CME Group and gave the stock an "equal weight" rating in a report on Thursday, July 24th. Finally, Wall Street Zen lowered shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Four analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $260.60.
Get Our Latest Research Report on CME
Insider Buying and Selling
In other news, Director William R. Shepard bought 256 shares of the stock in a transaction dated Wednesday, June 25th. The stock was purchased at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the transaction, the director owned 258,196 shares of the company's stock, valued at $69,849,763.88. The trade was a 0.10% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company's stock, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.
CME Group Price Performance
Shares of NASDAQ CME traded down $0.08 during midday trading on Friday, reaching $262.30. 1,537,684 shares of the stock traded hands, compared to its average volume of 1,837,493. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $94.53 billion, a PE ratio of 25.39, a P/E/G ratio of 4.75 and a beta of 0.43. CME Group Inc. has a one year low of $212.38 and a one year high of $290.79. The company's 50 day moving average is $273.60 and its 200 day moving average is $270.29.
CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the prior year, the company earned $2.56 EPS. On average, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio is currently 48.40%.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
